By John Q. Hosedrinker 
Purdue Pharma, the maker of OxyContin, is set to dissolve and be replaced by a new company focused on public good as a vast legal settlement resolves thousands of lawsuits. A federal judge delivered a criminal sentence to the company, admitting to a sophisticated crime scheme that fueled the opioid epidemic. Despite acknowledging the profound suffering caused, the judge expressed sympathy for victims while noting that no individuals will face punishment. The settlement includes billions in payments from the Sackler family and Purdue, with much of the funds earmarked for combating the opioid crisis and providing some compensation to individual victims.
Read the original article here
The very concept of Purdue Pharma dissolving after a judge approved its criminal sentence is, frankly, quite something. It’s a move that feels both significant and, to many, deeply inadequate. The idea of a company essentially getting a form of corporate death penalty is a powerful image, especially when we consider the immense suffering caused by the opioid crisis that OxyContin fueled. It’s a stark contrast to the jail time that individuals convicted of selling the drug face, and it highlights a persistent frustration: that those who engineered the crisis often escape personal accountability in the same way.
The Stamford, Connecticut-based company’s admission of failure to prevent the diversion of its powerful painkillers to the black market is a critical piece of the puzzle. They knew they didn’t have an effective program, yet they told the DEA they did. Beyond that, they admitted to a disturbing practice of paying doctors through a “speakers program” to prescribe these drugs, and even engaging an electronic medical records company to nudge doctors towards writing more opioid prescriptions. These weren’t accidental missteps; they were deliberate strategies to push a dangerous product.
This situation brings to mind parallels with other instances where corporations have faced major lawsuits and then seemingly re-emerged under a different guise. It’s a pattern that leaves many wondering if this dissolution is truly the end of the line, or merely a rebranding exercise to distance the individuals behind the company from past transgressions. The fear is that the company might simply dissolve, with key players moving assets and perhaps re-emerging later with a new name and a similar product, leaving the core issues unaddressed and the original architects of the crisis still wealthy.
The phrase “justice served” feels particularly hollow when considering the financial maneuvers that often accompany such corporate dissolutions. Questions immediately arise about whether those truly responsible, like members of the Sackler family, have already moved substantial wealth into private accounts, making it exceedingly difficult to extract true restitution or accountability. This is precisely why the idea that corporations should be treated as distinct legal “persons” is so contentious. It allows for a scenario where the entity can be dissolved, but the individuals behind it may largely escape the most severe consequences.
The judge herself acknowledged the profound disconnect, noting that she has sentenced convicted drug dealers to prison for selling OxyContin, often in the context of the broader epidemic. Her statement, that “It is not lost on me that those who started the epidemic will not serve a sentence,” encapsulates the widespread feeling of injustice. It suggests a two-tier system of justice, where financial resources and corporate structures can create a buffer against the kind of imprisonment that street-level drug dealers face.
The emergence of a new entity, such as Knoa Pharma, as a successor to Purdue, raises further concerns about the effectiveness of this dissolution. If the individuals who profited immensely from the crisis are able to distance themselves from the liability while still potentially benefiting from future ventures, then the dissolution feels more like a strategic maneuver than a genuine consequence. The suggestion that individuals like Craig Landau and Steve Miller, as well as past leaders like Michael Friedman and legal officers like Howard Udell, might continue to have influence, even indirectly, is troubling.
The core of the problem, as many see it, isn’t the corporation itself, but the individuals who made the decisions that led to such devastation. The Sackler family, in particular, is often cited as the ultimate architects of this tragedy. The notion of a “corporate death penalty” is discussed, but the underlying sentiment is that the human beings behind these corporate actions should face personal criminal charges and imprisonment, not just the abstract entity.
The debate over “corporate personhood” and its implications, especially in light of decisions like Citizens United, is central to this discussion. The argument is that if corporations are granted certain rights and privileges, they should also bear the full weight of responsibility for their actions, and this responsibility should extend to the individuals who direct them. The idea of dissolving a company as a punishment feels insufficient when it doesn’t directly translate into jail time for the people who profited from its illicit activities.
The hope, perhaps a naive one for some, is that the millions of internal Purdue documents that are to be made public could potentially be used to mount future criminal cases against the owners and former employees. This would be a significant step towards holding individuals accountable. However, the concern remains that the legal system and corporate structures are designed in ways that allow for immense wealth to insulate individuals from the full force of the law, even in the face of overwhelming evidence of harm.
Ultimately, the dissolution of Purdue Pharma, while a notable event, is seen by many as a symbolic gesture rather than a complete resolution. The lingering question is whether this action will truly lead to a reckoning for those who benefited from the opioid crisis, or if it will simply be another instance where the wealthy and powerful manage to navigate the consequences of their actions, leaving behind a legacy of pain and a sense of profound injustice for the countless victims. The desire for a more robust form of corporate accountability, one that directly targets the individuals responsible and ensures they face meaningful consequences, remains a powerful undercurrent in this ongoing narrative.